Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice

Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice

Abstract The progestin-based hormonal contraceptive Depot Medroxyprogesterone Acetate (DMPA) is widely used in sub-Saharan Africa, where HIV-1 is endemic. Meta-analyses have shown that women using DMPA are 40% more likely than women not using hormonal contraceptives to acquire Human Immunodeficiency...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jocelyn M. Wessels, Philip V. Nguyen, Danielle Vitali, Kristen Mueller, Fatemeh Vahedi, Allison M. Felker, Haley A. Dupont, Puja Bagri, Chris P. Verschoor, Alexandre Deshiere, Tony Mazzulli, Michel J. Tremblay, Ali A. Ashkar, Charu Kaushic
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/2c3623001ed1450a83368b237c5f59e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares